sprite-preloader
Freitag, 27.02.2015 Börsentäglich über 12.000 News von 507 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: 935166 ISIN: SE0000221723 Ticker-Symbol: M5E 
Aktie:
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDA AB Chart 1 Jahr
1-Woche-Intraday-Chart
MEDA AB 1-Woche-Intraday-Chart

Aktuelle News zu MEDA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
MEDA Aktie jetzt ab 2,99 Euro handeln!

► Artikel lesen
20.02.MEDA: DYMISTA approved in children 6 to 11 years of age with seasonal allergic rhinitis7
Regulatory News: Meda announces the approval by FDA (U.S. Food and Drug Administration) of Dymista, a single formulation azelastine hydrochloride and fluticasone propionate nasal...
► Artikel lesen
11.02.MEDA: Year-end Report, January-December 201425
Regulatory News: MEDA: (STO:MEDAA)(Pink Sheets:MDABY) January-December 2014[1] Net sales reached SEK 15,352 million (13,114), corresponding to an increase of 12%...
► Artikel lesen
05.02.MEDA: Invitation to Teleconference for Analysts, Investors and Journalists13
Presentation of Meda's Year-End Results 2014 On Wednesday, February 11th, 2015 at 8:00 CET, Meda will release its Year-End Results for 2014. Meda invites all analysts, investors and...
► Artikel lesen
29.01.BioDelivery Signs Agreement with Meda for Onsolis14

► Artikel lesen
06.01."Fressen oder gefressen werden": Pharmakonzern Meda will weiter zukaufen53

► Artikel lesen
02.01.Meda launches $276M rights issue to help pay for Rottapharm17

► Artikel lesen
30.12.Meda Reports Change In Number Of Shares, Votes3

► Artikel lesen
30.12.Change in Number of Shares and Votes in Meda5
Regulatory News: The rights issue recently conducted by Meda AB (STO:MEDA-A) (Pink Sheets:MDABY) has resulted in an increase of shares and votes during December 2014 of in total 33...
► Artikel lesen
10.12.MEDA: Meda's rights issue fully subscribed17
Regulatory News: Not for release, publication or distribution, directly or indirectly, in or into the United States, Canada, Australia, Japan, Hong Kong, New Zealand, South Africa...
► Artikel lesen
09.12.MEDA and Mountain Lion Agriculture Win 2014 Social Finance Innovator Award for Investments Making Positive Social/Environmental Impacts10
WATERLOO, ON--(Marketwired - December 09, 2014) - MEDA -- Mennonite Economic Development Associates -- and Mountain Lion Agriculture (MLA) were recognized on November...
► Artikel lesen
03.12.Cipla, Meda Sue Apotex To Enforce Dymista Patents8

► Artikel lesen
03.12.Meda Pharma, Cipla Sue Apotex To Enforce Dymista Patents2

► Artikel lesen
03.12.Meda and Cipla sue Apotex to enforce Dymista patents13
Regulatory News: Meda Pharmaceuticals Inc. and Cipla Ltd. today announced that they sued Apotex Inc. and Apotex Corp. ("Apotex") in Federal District Court in Delaware to enforce the...
► Artikel lesen
21.11.Madaus: Warten auf Meda48

► Artikel lesen
14.11.NASDAQ OMX Stockholm AB: Listing of subscription rights and paid subscription shares in Meda AB (167/14)14
With effect from November 19, 2014, the subscription rights in Meda AB will be quoted on the list for Equity rights. Quotation will continue up until and including December 2, 2014. Instrument: ...
► Artikel lesen
14.11.MEDA: Prospectus Concerning Meda's Rights Issue Published15
Regulatory News: Meda: (STO:MEDA-A) (Pink Sheets:MDABY) Not for release, publication or distribution, directly or indirectly, in or into the United States, Canada, Australia...
► Artikel lesen
11.11.NASDAQ OMX Stockholm AB: Adjustment of warrants in Meda due to rights issue8
In connection with rights issueall warrants with Meda AB as underlying instrument will be recalculated. The recalculation will be effective as from November 12, 2014. Please see the attached sheets...
► Artikel lesen
11.11.NASDAQ OMX Nordic: Derivatives: New ISIN codes following adjustment in Meda (75/14)7
NASDAQ OMX Derivatives Markets has carried out a re-calculation of options, forwards and futures in Meda AB (Meda) due to a rights issue. For details regarding the re-calculation please see exchange...
► Artikel lesen
11.11.NASDAQ OMX Nordic: Derivatives: Adjustment in Meda due to rights issue (74/14)8
The Extraordinary General Meeting (EGM) of Meda AB (Meda) held on November 6, 2014, approved a rights issue whereby shareholders are entitled to one (1) new share for every ten (10) shares held. The...
► Artikel lesen
11.11.XFRA CAPITAL ADJUSTMENT INFORMATION - 12.11.2014 - 150
FOLGENDE WERTPAPIERE WERDEN AM 11.11.2014 CUM KAPITALMASSNAHME UND AM 12.11.2014 EX KAPITALMASSNAHME GEHANDELT. THE FOLLOWING SHARES ARE TRADED CUM CAPITAL ADJUSTMENT ON 11.11.2014 AND EX CAPITAL...
► Artikel lesen
Seite:  Weiter >>
70 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
MEDA AB-Investoren interessieren sich auch für diese News

Unternehmen / AktienAktienkurs%Top-Nachrichten
NOVARTIS91,96+2,22 %Aktien im Fokus - Mittwoch, der 25.02.2015 - DAX, AAREAL BANK, METRO, COMMERZBANK, MERCK, AMGEN, AKAMAI TECHNOLOGIES, BIOMARIN PHARMA, SKYWORK SOLUTIONS, NORDEX, NOVARTIS, FRESENIUS MEDI, UNITED TECH, WELLS FARGO

► Artikel lesen
NOVO NORDISK42,23+1,15 %Novo Nordisk A/S: Novo Nordisk A/S - Share repurchase programme
Bagsværd, Denmark, 23 February 2015 - On 30 January 2015, Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003...
► Artikel lesen
SANOFI87,10-1,88 %dpa-AFX Überblick: ANALYSTEN-EINSTUFUNGEN vom 25.02.2015: AAREAL BANK, AIXTRON, ALLIANZ, ASTRAZENECA, AXA, BHP BILLITON, BMW, BRITISH AMERICAN TOBACCO, COMMERZBANK, CTS EVENTIM, DAIMLER, DIALOG SEMICONDUCTOR, ...
Ausgewählte Analysten-Einstufungen im dpa-AFX-Nachrichtendienst vom 25.02.2015 AAREAL BANK AG HANNOVER - Die NordLB hat Aareal Bank nach Zahlen von "Kaufen" auf "Halten" abgestuft und das...
► Artikel lesen
ASTRAZENECA62,000,00 %Exclusive: AstraZeneca spinning out its anti-infectives R&D unit in Waltham

► Artikel lesen
MYLAN50,41+1,81 %Aktien im Fokus - Donnerstag, der 26.02.2015 - DAX, GOLD, ALLIANZ, FREENET, FRESENIUS MEDI, MAN, MERCK, METRO, MUENCHENER RUECK, MYLAN

► Artikel lesen
Lade...